Revance Therapeutics Inc (RVNC) is ready for next Episode as it posted an annual sales of 234,040 K
A new trading day began on Monday, with Revance Therapeutics Inc (NASDAQ: RVNC) stock price down -3.70% from the previous day of trading, before settling